Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Tel-Tzure Tlalit Bussi, holds the title of VP, BD & Global Marketing at IceCure Medical Ltd..
On 2026-08-14, the insider transacted 101,483 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Tel-Tzure Tlalit Bussi (VP, BD & Global Marketing) was granted $0 of $ICCM
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.